Mutation Rate of the Hepatitis C Virus NS5B in Patients Undergoing Treatment With Ribavirin Monotherapy
- 31 May 2007
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 132 (5), 1757-1766
- https://doi.org/10.1053/j.gastro.2007.03.035
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005
- Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNAJournal of Virology, 2005
- 62 Is ribavirin antiviral effect in humans mediated by mutagenic properties resulting in error catastrophe?Journal of Hepatology, 2004
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young childrenPublished by Wiley ,2004
- Identification of a Ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapyHepatology, 2003
- Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic RepliconsJournal of Virology, 2003
- Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication SystemJournal of Virology, 2002
- Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trialHepatology, 1997
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Prospects for Treatment of Viral Hemorrhagic Fevers with Ribavirin, a Broad-Spectrum Antiviral DrugClinical Infectious Diseases, 1989